Overview

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

Status:
Not yet recruiting
Trial end date:
2026-05-14
Target enrollment:
Participant gender:
Summary
The aim of this study is to reduce pulmonary complications in adult patients undergoing abdominal or thoracic surgery in COVID-19 exposed hospital environments. A Trial in Low and Middle Income Countries (LMICs)
Phase:
Phase 3
Details
Lead Sponsor:
University of Birmingham
Collaborators:
Christian Medical College and Hospital, Ludhiana, India
Hospital Español Veracruz
Istituto Clinico Humanitas
Kigali University Teaching Hospital
Tamale Teaching Hospital, Ghana.
Université d'Abomey-Calavi
University of Cape Town
University of Edinburgh
University of Lagos, Nigeria
University of Witwatersrand, South Africa
Treatments:
Hydroxychloroquine
Lopinavir
Ritonavir